Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News

Werewolf Therapeutics (HOWL) shares more than doubled on Friday morning as investors reacted to the company’s definitive agreement to merge with privately held Ambros Therapeutics.

Once the transaction is completed, HOWL shareholders will retain about 6.8% ownership of the joint company, its management revealed in a press release on Aug. 21.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.